| Morgan Cheyenne Eaton, | |
|
101 7th St Sw, Orange City, IA 51041-1996 | |
| (712) 707-7000 | |
| Not Available |
| Full Name | Morgan Cheyenne Eaton |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 101 7th St Sw, Orange City, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275237620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Morgan Cheyenne Eaton, 101 7th St Sw, Orange City, IA 51041-1996 Ph: () - | Morgan Cheyenne Eaton, 101 7th St Sw, Orange City, IA 51041-1996 Ph: (712) 707-7000 |
News Archive
Global funding for efforts to fight malaria, which stood at $2 billion at the end of 2009, have "helped to contain the disease," but is "far short of the estimated $6 billion required annually to expand" efforts to fight it, the Roll Back Malaria Partnership said on Thursday, Reuters reports. The statements came as the partnership released a report (.pdf) that examined a decade's worth of global funding for malaria and its impact on fighting the disease (Hardach, 3/18).
The American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) will issue the first comprehensive clinical guidelines to help health care practitioners identify patients with cerumen (commonly referred to as earwax) impaction. The guidelines emphasize evidence-based management of cerumen impaction by clinicians, and inform patients of the purpose of ear wax in hearing health.
Mylan Inc. today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per share) payable on Aug. 16, 2010, to holders of preferred stock of record as of Aug. 1, 2010.
Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced that it is funding a clinical trial of curcumin in people with cystic fibrosis (CF).
While nearly three-quarters of Americans believe that the public health system would respond fairly in a bioterrorist event, African-Americans and Asians adhere to this view in smaller proportions, perhaps because of past discriminatory policies put in place by health officials, according to a new UCLA study.
› Verified 4 days ago
Bailey Varpness, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 101 7th St Sw, Orange City, IA 51041 Phone: 712-707-7000 | |
Nicholas Joseph Fenske, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 101 7th St Sw, Orange City, IA 51041 Phone: 712-707-7000 | |
Lori L Anderson, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln Cir Se, Orange City, IA 51041 Phone: 712-737-2000 | |
Kaylee Marie Frenette, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 101 7th St Sw, Orange City, IA 51041 Phone: 715-210-1021 | |
Christopher Steven Canu, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 101 7th St Sw, Orange City, IA 51041 Phone: 712-707-7467 | |
Jordan Grosdidier, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 101 7th St Sw, Orange City, IA 51041 Phone: 712-707-7000 | |
Melinda Kubesh, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 101 7th St Sw, Orange City, IA 51041 Phone: 712-707-7000 |